Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) (TTP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Beth Israel Medical Center
Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party):
Beth Israel Medical Center Identifier:
First received: August 4, 2009
Last updated: April 19, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)